Cargando…

Toxoplasma ROP16(I/III) ameliorated inflammatory bowel diseases via inducing M2 phenotype of macrophages

BACKGROUND: Inflammatory bowel disease (IBD) is characterized by chronic and non-specific inflammation of the intestinal mucosa and mainly includes ulcerative colitis and Crohn's disease. AIM: To explore the beneficial effect of ToxoROP16(I/III)-induced M2 phynotype macrophages in homeostasis o...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yong-Wei, Xing, Rui-Xin, Zhang, Wen-Hui, Li, Lu, Wu, Yi, Hu, Jing, Wang, Cong, Luo, Qing-Li, Shen, Ji-Long, Chen, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906210/
https://www.ncbi.nlm.nih.gov/pubmed/31832003
http://dx.doi.org/10.3748/wjg.v25.i45.6634
_version_ 1783478308561747968
author Xu, Yong-Wei
Xing, Rui-Xin
Zhang, Wen-Hui
Li, Lu
Wu, Yi
Hu, Jing
Wang, Cong
Luo, Qing-Li
Shen, Ji-Long
Chen, Xi
author_facet Xu, Yong-Wei
Xing, Rui-Xin
Zhang, Wen-Hui
Li, Lu
Wu, Yi
Hu, Jing
Wang, Cong
Luo, Qing-Li
Shen, Ji-Long
Chen, Xi
author_sort Xu, Yong-Wei
collection PubMed
description BACKGROUND: Inflammatory bowel disease (IBD) is characterized by chronic and non-specific inflammation of the intestinal mucosa and mainly includes ulcerative colitis and Crohn's disease. AIM: To explore the beneficial effect of ToxoROP16(I/III)-induced M2 phynotype macrophages in homeostasis of IBDs through downregulation of M1 inflammatory cells. METHODS: RAW264.7 macrophages stimulated by lipopolysaccharide (LPS) (M1 cells) were co-cultured with Caco-2 cells as an inflammatory model of IBD in vitro. The expression of ToxoROP16(I/III) was observed in RAW264.7 macrophages that were transfected with pEGFP-rop16(I/III). The phenotypes of M2 and M1 macrophage cells were assessed by quantitative real-time reverse transcriptase polymerase chain reaction and the expression of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, transforming growth factor (TGF)-β1, IL-10, inducible nitric oxide synthase (iNOS), and arginase-1 (Arg-1) was detected. The expression of iNOS, Arg-1, signal transducer and activator of transcription 3 (Stat3), p-Stat3, Stat6, p-Stat6, programmed death ligand-2 (PD-L2), caspase-3, -8, and -9 was analyzed by Western blotting, and Griess assays were performed to detect nitric oxide (NO). TNF-α, IL-1β, IL-6, TGF-β1, and IL-10 expression in the supernatants was detected by enzyme-linked immunosorbent assay, and Caco-2 cell apoptosis was determined by flow cytometry after mixing M1 cells with M2 cells in a Caco-2 cell co-culture system. RESULTS: M1 cells exhibited significantly increased production of iNOS, NO, TNF-α, IL-1β, and IL-6, while ToxoROP16(I/III) induced macrophage bias to M2 cells in vitro, showing increased expression of Arg-1, IL-10 and TGF-β1 and elevated production of p-Stat3 and p-Stat6. The mixed M1 and M2 cell culture induced by ToxoROP16(I/III) exhibited decreased production of NO and iNOS and upregulated expression of Arg-1 and PD-L2. Accordingly, Caco-2 cells became apoptotic, and apoptosis-associated proteins such as caspase-3, -8 and -9 were dampened during co-culture of M1 and M2 cells. Flow cytometry analysis showed that co-culture of M1 cells with Caco-2 cells facilitated the apoptosis of Caco-2 cells, but co-culture of M1 and M2 cells alleviated Caco-2 cell apoptosis. CONCLUSION: ToxoROP16(I/III)-induced M2 macrophages inhibited apoptosis of Caco-2 cells caused by M1 macrophages. This finding may help gain a better understanding of the underlying mechanism and represent a promising therapeutic strategy for IBDs.
format Online
Article
Text
id pubmed-6906210
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-69062102019-12-12 Toxoplasma ROP16(I/III) ameliorated inflammatory bowel diseases via inducing M2 phenotype of macrophages Xu, Yong-Wei Xing, Rui-Xin Zhang, Wen-Hui Li, Lu Wu, Yi Hu, Jing Wang, Cong Luo, Qing-Li Shen, Ji-Long Chen, Xi World J Gastroenterol Basic Study BACKGROUND: Inflammatory bowel disease (IBD) is characterized by chronic and non-specific inflammation of the intestinal mucosa and mainly includes ulcerative colitis and Crohn's disease. AIM: To explore the beneficial effect of ToxoROP16(I/III)-induced M2 phynotype macrophages in homeostasis of IBDs through downregulation of M1 inflammatory cells. METHODS: RAW264.7 macrophages stimulated by lipopolysaccharide (LPS) (M1 cells) were co-cultured with Caco-2 cells as an inflammatory model of IBD in vitro. The expression of ToxoROP16(I/III) was observed in RAW264.7 macrophages that were transfected with pEGFP-rop16(I/III). The phenotypes of M2 and M1 macrophage cells were assessed by quantitative real-time reverse transcriptase polymerase chain reaction and the expression of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, transforming growth factor (TGF)-β1, IL-10, inducible nitric oxide synthase (iNOS), and arginase-1 (Arg-1) was detected. The expression of iNOS, Arg-1, signal transducer and activator of transcription 3 (Stat3), p-Stat3, Stat6, p-Stat6, programmed death ligand-2 (PD-L2), caspase-3, -8, and -9 was analyzed by Western blotting, and Griess assays were performed to detect nitric oxide (NO). TNF-α, IL-1β, IL-6, TGF-β1, and IL-10 expression in the supernatants was detected by enzyme-linked immunosorbent assay, and Caco-2 cell apoptosis was determined by flow cytometry after mixing M1 cells with M2 cells in a Caco-2 cell co-culture system. RESULTS: M1 cells exhibited significantly increased production of iNOS, NO, TNF-α, IL-1β, and IL-6, while ToxoROP16(I/III) induced macrophage bias to M2 cells in vitro, showing increased expression of Arg-1, IL-10 and TGF-β1 and elevated production of p-Stat3 and p-Stat6. The mixed M1 and M2 cell culture induced by ToxoROP16(I/III) exhibited decreased production of NO and iNOS and upregulated expression of Arg-1 and PD-L2. Accordingly, Caco-2 cells became apoptotic, and apoptosis-associated proteins such as caspase-3, -8 and -9 were dampened during co-culture of M1 and M2 cells. Flow cytometry analysis showed that co-culture of M1 cells with Caco-2 cells facilitated the apoptosis of Caco-2 cells, but co-culture of M1 and M2 cells alleviated Caco-2 cell apoptosis. CONCLUSION: ToxoROP16(I/III)-induced M2 macrophages inhibited apoptosis of Caco-2 cells caused by M1 macrophages. This finding may help gain a better understanding of the underlying mechanism and represent a promising therapeutic strategy for IBDs. Baishideng Publishing Group Inc 2019-12-07 2019-12-07 /pmc/articles/PMC6906210/ /pubmed/31832003 http://dx.doi.org/10.3748/wjg.v25.i45.6634 Text en ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Basic Study
Xu, Yong-Wei
Xing, Rui-Xin
Zhang, Wen-Hui
Li, Lu
Wu, Yi
Hu, Jing
Wang, Cong
Luo, Qing-Li
Shen, Ji-Long
Chen, Xi
Toxoplasma ROP16(I/III) ameliorated inflammatory bowel diseases via inducing M2 phenotype of macrophages
title Toxoplasma ROP16(I/III) ameliorated inflammatory bowel diseases via inducing M2 phenotype of macrophages
title_full Toxoplasma ROP16(I/III) ameliorated inflammatory bowel diseases via inducing M2 phenotype of macrophages
title_fullStr Toxoplasma ROP16(I/III) ameliorated inflammatory bowel diseases via inducing M2 phenotype of macrophages
title_full_unstemmed Toxoplasma ROP16(I/III) ameliorated inflammatory bowel diseases via inducing M2 phenotype of macrophages
title_short Toxoplasma ROP16(I/III) ameliorated inflammatory bowel diseases via inducing M2 phenotype of macrophages
title_sort toxoplasma rop16(i/iii) ameliorated inflammatory bowel diseases via inducing m2 phenotype of macrophages
topic Basic Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906210/
https://www.ncbi.nlm.nih.gov/pubmed/31832003
http://dx.doi.org/10.3748/wjg.v25.i45.6634
work_keys_str_mv AT xuyongwei toxoplasmarop16iiiiamelioratedinflammatoryboweldiseasesviainducingm2phenotypeofmacrophages
AT xingruixin toxoplasmarop16iiiiamelioratedinflammatoryboweldiseasesviainducingm2phenotypeofmacrophages
AT zhangwenhui toxoplasmarop16iiiiamelioratedinflammatoryboweldiseasesviainducingm2phenotypeofmacrophages
AT lilu toxoplasmarop16iiiiamelioratedinflammatoryboweldiseasesviainducingm2phenotypeofmacrophages
AT wuyi toxoplasmarop16iiiiamelioratedinflammatoryboweldiseasesviainducingm2phenotypeofmacrophages
AT hujing toxoplasmarop16iiiiamelioratedinflammatoryboweldiseasesviainducingm2phenotypeofmacrophages
AT wangcong toxoplasmarop16iiiiamelioratedinflammatoryboweldiseasesviainducingm2phenotypeofmacrophages
AT luoqingli toxoplasmarop16iiiiamelioratedinflammatoryboweldiseasesviainducingm2phenotypeofmacrophages
AT shenjilong toxoplasmarop16iiiiamelioratedinflammatoryboweldiseasesviainducingm2phenotypeofmacrophages
AT chenxi toxoplasmarop16iiiiamelioratedinflammatoryboweldiseasesviainducingm2phenotypeofmacrophages